rupatadine has been researched along with orabase in 2 studies
Studies (rupatadine) | Trials (rupatadine) | Recent Studies (post-2010) (rupatadine) | Studies (orabase) | Trials (orabase) | Recent Studies (post-2010) (orabase) |
---|---|---|---|---|---|
116 | 43 | 62 | 3,694 | 227 | 1,883 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baltodano Viales, E; Calvo Guzmán, B; Carazo Berrocal, G; Castillo Henríquez, L; Madrigal Redondo, G; Vargas Zúñiga, R | 1 |
Mohamed, MZ; Mohammed, HH | 1 |
2 other study(ies) available for rupatadine and orabase
Article | Year |
---|---|
Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach.
Topics: Carboxymethylcellulose Sodium; Cellulose; Chemistry, Pharmaceutical; Cyproheptadine; Drug Compounding; Excipients; Fumarates; Lactose; Solubility; Starch; Stearic Acids; Tablets; Technology, Pharmaceutical | 2019 |
Rupatadine protects the intestinal mucosa from injury by 5-flurouracil via modulation of inflammation, apoptosis and intestinal permeability.
Topics: Animals; Apoptosis; Aspartic Acid Proteases; Carboxymethylcellulose Sodium; Caspase 3; Cysteine; Fluorouracil; Glutathione; Histamine; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Irritants; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Permeability; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2022 |